FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to quinolines substituted by phosphorus-containing group of formula and applicable in medicine, wherein Z represents
V1 and V2 are independently specified in hydrogen or halogen; one of R and R` represent phosphorus-containing substitute Q; the other one is specified in hydrogen or methoxyl; wherein the phosphorus-containing substitute Q represents
A represents O; L represents C1-6alkyl; J represents NH or C3-6heterocycloalkyl and J is optionally substituted by G3; X is absent or represents -C(=O)-; X is absent or represents C1-6alkyl; each of R1 and R2 are independently specified in C1-6alkyl or C1-6alkoxy; G3 represents C1-6alkyl, R3S(=O)m-, R5C(=O)- or R3R4NC(=O)-; R3, R4 and R5 are independently specified in 3 or C1-6alkyl; m is equal to 0-2.
EFFECT: there are presented new protein kinase inhibitors effective for treating the diseases associated with abnormal protein kinase activity.
20 cl, 42 ex, 8 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
QUINOLYL-CONTAINING COMPOUND OF HYDROXAMIC ACID, METHOD FOR THEREOF OBTAINING AND APPLICATION IN TREATMENT OF DISEASES, CAUSED BY ABNORMAL PROTEINKINASE AND/OR HYSTONE DEACETYLASE ACTIVITY | 2011 |
|
RU2573633C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
ANTICANCER AGENT INVOLVING COMBINATIONS OF KINASE INHIBITORY COMPOUNDS | 2011 |
|
RU2560683C2 |
PHARMACEUTICALLY ACTIVE COMPOUNDS AS Axl INHIBITORS | 2011 |
|
RU2573834C2 |
NOVEL PYRIDINE DERIVATIVE AND DERIVATIVE OF PYRIMIDINE (3) | 2006 |
|
RU2362771C1 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
NITROGEN-CONTAINING AROMATIC DERIVATIVES, THEIR USING, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR TREATMENT | 2001 |
|
RU2264389C2 |
QUINOLINE OR QUINAZOLINE DERIVATIVE USED AS AXL INHIBITOR | 2014 |
|
RU2666895C2 |
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
Authors
Dates
2015-05-20—Published
2011-04-06—Filed